McKesson International — Operating Income remained flat by 0.0% to -$53.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 166.8%, from $79.75M to -$53.25M. Over 4 years (FY 2021 to FY 2025), International — Operating Income shows a downward trend with a 54.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals improved operational efficiency or stronger market demand in international territories, while a decrease indicates margin pressure or rising costs.
This metric measures the core profitability of the international business segment after deducting operating expenses fro...
Equivalent to 'Segment Operating Profit' or 'Segment EBIT' reported by major global pharmaceutical wholesalers.
mck_segment_international_operating_income| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$37.00M | -$968.00M | $136.00M | $319.00M | -$213.00M |
| YoY Change | — | <-999% | +114.0% | +134.6% | -166.8% |